Facebook
Twitter
LinkedIn
Forward
Case Discussions in OAB, BPH, and More: Managing the Complex Patient (CME/CE Symposium at AUA2024)
REGISTER NOW
Click Here to register and add this program to your AUA2024 meeting schedule.
You may also register through this site by clicking "Register/Take Course" above.
This CME/CE symposium occurs during the 2024 AUA Annual Meeting.
Saturday, May 4, 2024
7:30 AM – 8:00 AM CT Complimentary Registration and Breakfast
8:00 AM – 9:00 AM CT CME/CE Symposium
Henry B. Gonzalez Convention Center
Room 217AB
900 East Market Street
San Antonio, Texas
Target Audience
This educational activity is intended for urologists, urogynecologists, physician assistants, nurse practitioners, nurses, and other clinicians caring for patients with overactive bladder.
Learning Objectives
After completing this activity, participants will be better able to:
- Identify central nervous system effects of anticholinergic agents used to treat overactive bladder
- Recount findings of clinical trial data on new treatments for overactive bladder
- Design appropriate evidence-based treatment strategies for patients with complicating factors such as benign prostatic hyperplasia
Faculty
 | David Staskin, MD (Chair) Associate Professor of Urology Tufts University School of Medicine St. Elizabeth’s Medical Center Boston, Massachusetts |
 | Aqsa A. Khan, MD |
 | Eric S. Rovner, MD |
Disclosure Policy
MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.
Faculty
Aqsa A. Khan, MD, has no relevant commercial relationships to disclose.
Eric S. Rovner, MD, is a consultant for BlueWind Medical; is a contracted researcher for AbbVie Inc and Sumitomo Pharma America, Inc*; and has stock options that have not been exercised in UroCure.
David Staskin, MD, is a consultant for Astellas Pharma Inc*, Azura Bio, Inc, Quillitin Pharma Pte Ltd, and Sumitomo Pharma America, Inc, and UroCure; is on the speakers bureau for Astellas Pharma Inc* and Sumitomo Pharma America, Inc; and is a contracted researcher for Astellas Pharma Inc* and Sumitomo Pharma America, Inc.
* The financial relationship existed during the last 24 months but has now ended
Peer Reviewer
This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.
Planners, Managers, and Writers
MedEdicus planners, managers, and writers have no relevant commercial relationships to disclose.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. You must attend the entire symposium as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
For Physicians
ACCME Accreditation Statement
MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Credit Designation Statement
MedEdicus LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For Nurses
Interprofessional Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by MedEdicus LLC and Amedco LLC. Amedco LLC is jointly accredited by the ACCME, the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Nursing Credit
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.
Disclosure of Commercial Support
This continuing medical education activity is supported through an educational grant from Sumitomo Pharma America, Inc.
Off-Label Discussion
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Americans With Disabilities Act 
MedEdicus fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please contact info@mededicus.com with any special needs (eg, physical, dietary) prior to the program.
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC, Amedco LLC, or Sumitomo Pharma America, Inc.
This CME/CE activity is copyrighted to MedEdicus LLC ©2024. All rights reserved. MedEdicus does not claim copyright to material included herein owned by third parties for which attribution or citation has been made. 320
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
Please login if you already have an account on the MedEdicus Learning Portal OR Register to create an account. Then click "Take Course" to sign up for this symposium.
We look forward to seeing you in San Antonio on May 4!
If you do not receive an email confirmation, please check your spam folder or email info@mededicus.com.